Share on StockTwits

Bunge (NYSE:BG) has earned a consensus recommendation of “Buy” from the thirteen brokerages that are covering the stock, American Banking reports. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $84.58.

Bunge (NYSE:BG) traded up 0.99% during mid-day trading on Thursday, hitting $79.18. 113,674 shares of the company’s stock traded hands. Bunge has a 52 week low of $65.74 and a 52 week high of $84.18. The stock has a 50-day moving average of $78.55 and a 200-day moving average of $79.07. The company has a market cap of $11.798 billion and a price-to-earnings ratio of 50.45.

Bunge (NYSE:BG) last released its earnings data on Thursday, February 13th. The company reported $1.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.15 by $0.80. The company had revenue of $16.38 million for the quarter, compared to the consensus estimate of $16.30 million. During the same quarter in the previous year, the company posted $0.57 earnings per share. The company’s revenue for the quarter was down 3.9% on a year-over-year basis. On average, analysts predict that Bunge will post $7.03 earnings per share for the current fiscal year.

BG has been the subject of a number of recent research reports. Analysts at TheStreet upgraded shares of Bunge from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, analysts at Macquarie initiated coverage on shares of Bunge in a research note on Tuesday, December 17th. They set an “outperform” rating on the stock.

Bunge Limited is a holding company, and its operations are conducted through its subsidiaries. The Company is a global agribusiness and food company with integrated operations that stretch from the farm fields to consumer foods.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.